The Hematology/Oncology Division is strongly committed to the training in and conduct of clinical and basic science research as well as to developing outstanding future oncologists and hematologists. Our laboratories are located in the new, cutting edge Wisconsin Institutes for Medical Research and the Clinical Science Center attached to UW Hospital and Clinics.
Our cutting edge research includes individual labs and disease oriented working groups (DOWGS) working on treatments for solid tumors, hematologic malignancies and clotting disorders, cancer survivorship and palliative care. The division also has two NIH Kirschstein National Research Service Award T32 training programs in Hematology and Oncology. These training programs provide advanced opportunities to focus on clinical or laboratory research, and translational multi-disciplinary training to promote well-prepared successful academic careers in investigational cancer research.
Physician Scientist Training in Cancer Medicine (PI-McNeel) trains post doctoral M.D. trainees
Research Training in Hematology (PI- Sheehan) trains pre- and post-doctoral trainees.
Basic and Clinical Research
Hematologic Clinical research within the Division focuses both on treatment of hematologic malignancies such as, acute leukemia, chronic leukemia, myelodysplastic syndromes, myeloma, Hodgkin's lymphoma, and non-Hodgkin's lymphomas, and novel approaches to HSCT, and on treatment of benign hematologic disorders. The clinics are a tertiary referral center for a wide variety of other disorders of blood coagulation, platelets, red blood cells, and white blood cells. Laboratory research within the Division focuses on blood coagulation disorders, cell adhesion and migration, protein chemistry, and transfusion medicine.
Medical Oncology faculty and staff are actively involved in interdisciplinary, translational cancer research and experimental therapeutics within the University of Wisconsin Comprehensive Carbone Cancer Center. Clinical research is conducted for all solid tumor types including brain, breast, gynecologic, head and neck, gastrointestinal, lung, melanoma, urological and palliative care. At any one time, the UWCCC manages over 200 clinical trials of investigational drugs. With an emphasis on cancer research, the Wisconsin Institutes for Medical Research (WIMR) at the University of Wisconsin School of Medicine and Public Health in Madison is designed to allow researchers to work with scientists from other disciplines, speeding the transfer of science to patients.
Search for clinical trials available at the UW Carbone Cancer Center.
These faculty members are physician scientists with active lab research programs.
- Dr. Mark Albertini
- Dr. Fotis Asimakopoulos
- Dr. Mark Burkard
- Dr. Dustin Deming
- Dr. Peiman Hematti
- Dr. Joshua Lang
- Dr. Douglas McNeel
- Dr. Dean Mosher
- Dr. Lixin Rui
- Dr. John Sheehan
- Dr. Bradford Schwartz